Minipigs: Applications in Toxicology

Larry D. Brown1, Alain Stricker‐Kongrad1, Guy F. Bouchard1

1 Sinclair Research Center, LLC and Sinclair BioResources, LLC, Auxvasse, Missouri
Publication Name:  Current Protocols in Toxicology
Unit Number:  Unit 1.11
DOI:  10.1002/0471140856.tx0111s56
Online Posting Date:  May, 2013
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library


Minipigs are accepted models for a variety of drug preclinical and nonregulatory toxicology studies. Acute, subchronic and chronic studies are possible using all routes of administration. Minipigs have distinct size advantages over domestic pigs. There exist some minor limitations with minipigs, but for the most part they offer well correlated models to humans for dermal and systemic toxicology assessments. Phototoxicology and reproductive toxicology usage is expanding. Minipig size, anatomy, physiology, metabolism, and genetics generally correlate well to human factors. The minipig makes an appropriate model for toxicology. Curr. Protoc. Toxicol. 56:1.11.1‐1.11.19. © 2013 by John Wiley & Sons, Inc.

Keywords: minipig; toxicology; animal model

PDF or HTML at Wiley Online Library

Table of Contents

  • Introduction
  • Selection of Animal Species
  • Numbers of Minipigs Studied: Europe Versus USA
  • Advantages and Limitations of Minipig Toxicology Models
  • Miniswine Lineage/Breed Selection for Toxicology
  • Correlation of Toxicology Study Findings
  • Dermatotoxicology/Cutaneous Safety Assessment
  • Ocular Safety Evaluation
  • Cardiovascular Toxicology
  • Nephrotoxicology
  • Developmental Immunology and Immunotoxicology
  • Liver Metabolism and Hepatotoxicology
  • Toxicokinetic Studies
  • Device Safety
  • Safety Pharmacology
  • Reproductive and Developmental Toxicology (DART)
  • Phototoxicology
  • Hematopoietic Toxicology
  • Minipig Repeat Intravenous Infusion Studies
  • Serum Enzymes in Toxicology
  • Confounders in Toxicology
  • Human Correlation/Concordance for Toxicology
  • Lineage Selection
  • Summary and the Future
  • Literature Cited
  • Figures
  • Tables
PDF or HTML at Wiley Online Library


PDF or HTML at Wiley Online Library



Literature Cited

Literature Cited
  American Physiological Society (APS). 2006. FY 2004 USDA Regulated Animals in Research. Viewed on June 25, 2006 http://www.the‐
   Anzenbacher, P., Anzenbacherova, E., Zuber, R., Soucek, P., and Guengerich, F.P. 2002. Letter to the editor, pig and minipig cytochromes p450. Drug Metab. Dispos. 30:100‐102.
   Anzenbacherova, E., Anzenbacher, P., Svoboda, Z., Ulrichova, J., Kvetina, J., Zoulova, J., Perlik, F., and Martinkova, J. 2003. Minipig as a model for drug metabolism in man: Comparison of in vitro and in vivo metabolism of propafenone. Biomed. Papers 147:155‐159.
   Beermann, D.H., Marple, D.N., Hirschinger, C.W., and Cassens, R.G. 1975. Variation of plasma creatine phosphokinase activity in swine. J. Anim. Sci. 40:75‐77.
   Bode, G., Clausing, P., Gervaios, F., Loegsted, J., Luft, J., Nogues, V., Sims, J.; Steering Group of the RETHINK Project. 2010. The utility of the minipig as an animal model in regulatory toxicology. J. Pharm. Toxicol. Methods 62:196‐220.
   Bollen, P. and Ritskes‐Hoitinga, M. 2007. Chapter 12. The welfare of pigs and minipigs. In The Welfare of Laboratory Animals. (E. Kalista, ed.) pp. 275‐289. Springer.
   Boone, L., Meyer, D., Cusick, P., Ennulat, D., Bolliger, A.P., Everds, N., Meador, V., Elliott, G., Honor, D., Bounous, D., and Jordan, H. 2005. Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet. Clin. Pathol. 34:182‐188.
   Boyd, J.W. 1983. The mechanism relating to increases in plasma enzymes and isoenzymes in diseases of animals. Vet. Clin. Pathol. 12:9‐24.
   Brinck, P. 2000a. Chapter 17. Surgical preparation of the minipig. In Handbook of Preclinical Continuous Intravenous Infusion. (G. Healing and D. Smith, eds.) pp. 225‐232. Taylor and Francis, London.
   Brinck, P. 2000b. Chapter 18. Multidose infusion toxicity studies in the minipig. In Handbook of Preclinical Continuous Intravenous Infusion. (G. Healing and D. Smith, eds.) pp. 233‐240. Taylor and Francis, London.
   Calabrese, E.J. 1991. Principles of Animal Extrapolation. CRC Press, Boca Raton, Fla.
   Cornelius, C.E. 1989. Liver function. In Clinical Biochemistry of Domestic Animals. (J.J. Kaneko, ed.) pp. 364‐397. Academic Press, New York.
   Davis, J.L., Gilger, B.C., and Robinson, M.R. 2004. Novel approaches to ocular drug delivery. Curr. Opin. Mol. Ther. 6:195‐205.
   Duncan, J.R. and Prasse, K.W. 1977. Chapter 7. Liver. Veterinary Laboratory Medicine‐Clinical Pathology. 2nd Ed. Iowa State University Press, Ames, Iowa.
   EMEA. 2008. Non‐Clinical Guideline on Drug‐Induced Hepatotoxicity. EMEA/CHMP/SWP/150115/2006
   Evans, G.O. 2008. Animal Hematotoxicology: A Practical Guide for Toxicologists and Biomedical Researchers. CRC Press, Boca Raton, Fla.
   Friis, C. 1998. Renal function in swine. Scand. J. Lab. Anim. Sci. 25:57.
   Gad, S.C. 2000. Pigs and ferrets as models in toxicology and biological safety assessment. Int. J. Toxicol. 19:149‐168.
   Gad, S.C. 2012. Chapter 37. The minipig and pig in medical device research. In The Minipig in Biomedical Research. (P.A. McAnulty, A.D. Dayan, N‐C. Ganderup, and K.L. Hastings eds.) pp. 549‐561. CRC Press/Taylor & Francis, Boca Raton, Fla.
   Gad, S.C., Dincer, Z., Svendsen, O., and Skaanild, M.T. 2008. Chapter 10. The minipig‐toxicology, pathology and metabolism. In Animal Models in Toxicology, 2nd ed. (S.C. Gad, ed.) pp. 731‐771. Informa Healthcare, New York.
   Ganderup, N‐C. 2012. Chapter 39. Adverse responses to drugs in man‐critical comparison of reported toxicological findings in minipigs and humans. In The Minipig in Biomedical Research. (P.A. McAnulty, A.D. Dayan, N‐C. Ganderup, and K.L. Hastings, eds.) pp. 573‐594. CRC Press/Taylor & Francis, Boca Raton, Fla.
   Gojmerac, T., Kartal, B., Zuric, M., Curic, S., and Mitak, M. 1995. Serum biochemical and histopathological changes related to the hepatic function in pigs following atrazine treatment. J. Appl. Toxicol. 15:233‐236.
   Goranov, K.H. 1984. 5′‐nucleotidase activity in organs of cattle, sheep, and swine. Vet. Med. Nauki 21:37‐41.
   Helm, R.M., Ermel, R.W., and Frick, O.L. 2003. Nonmurine animal models of food allergy. Environ. Health Perspect. 111:239‐244.
   Hendricksen, K., Moonen, P.M.J., van der Heijden, A.G., Molkenboer‐Kuenen, J., Hulsbergen‐van de Kaa, C.A., and Witjes, J.A. 2006. Potential and toxicity of intravesical pemetrexed: A preclinical study in pigs. Clin. Cancer Res. 12:2597‐2601.
   Hinton, D.M. 2000. US FDA “Redbook II” immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins. Toxicol. Pathol. 28:467‐478.
   Hinton, D.M., and Khan, M.A. 1989. Evaluation of the miniature swine for use in immunotoxicity assessment. Int. J. Toxicol. 8:1039‐1052.
   Hite, C.M. 2009. Urinary Catheterization of Male Swine. Abstract/Poster at AALAS National Meeting, Denver, CO.
   Hoffmann, W.E., and Solter, P.F. 2008. Chapter 12. Diagnostic enzymology of domestic animals. In Clinical Biochemistry of Domestic Animals. 6th Ed. (J.J. Kaneko, J.W. Harvey, and M.L. Bruss, eds.) pp. 357. Academic Press, San Diego.
   Jacobs, A. 2006. Use of nontraditional animals for evaluation of pharmaceutical products. Expert Opin. Drug Metab. Toxicol. 2:345‐349.
   Jones, R.D., Stuart, B.P., Greufe, N.P., and Landes, A.M. 1999. Electrophysiology and pathology evaluation of the Yucatan pig as a non‐rodent animal model for regulatory and mechanistic toxicology studies. Lab. Anim. 33:356‐365.
   Jorgensen, K.D. 1998. Minipig in reproductive toxicology. Scand. J. Lab. Anim. Sci. 25:63‐75.
   Kahn, C.M. (ed.) 2008. Merck veterinary manual online. Serum enzyme concentrations. In Hepatic Disease in Large Animals: Introduction. Merial/Merck & Co., Whitehouse Station, NJ.
   Kahn, M. 1984. The minipig: Advantages and disadvantages as a model in toxicity testing. Int. J. Toxicol. 3:337‐342.
   Kaneko, N., Fuji, Micr. Ltd.; Kawaguchi, H., Kagoshima, University 2011.
   Kano, M., Toyoshi, T., Iwasaki, S., Kato, M., Shimizu, M., and Ota, T. 2005. QT PRODACT: Usability of miniature pigs in safety pharmacology studies: Assessment for drug‐induced QT interval prolongation. J. Pharmacol. Sci. 99:501‐511.
   Leigh, H., Forbes, P.D., Lawson, C., Kim, D.Y., White, D., Brown, L.D., Wehmeier, D.R., Liu, J., and Bouchard, G.F. 2012. Miniature swine model of phototoxicity testing. Photodermatol. Photoimmunol. Photomed. 28:34‐41.
   Ludemann, L., Nafz, B., Elsner, F., Grosse‐Siestrup, C., Meissler, M., Kaufels, N., Rehbein, H., Persson, P.B., Michaely, H.J., Lengsfeld, P., Voth, M., and Gutberlet, M. 2009. Absolute quantification of regional renal blood flow in swine by dynamic contrast‐enhanced magnetic resonance imaging using a blood pool contrast agent. Invest. Radiol. 44:125.
   Makin, A., Mortensen, J.T., and Brock, W.J. 2012. Ch12. Dermal toxicity studies: Skin architecture, metabolism, penetration, and toxicological and pharmaceutical methods. In The Minipig in Biomedical Research. (P.A. McAnulty, A.D. Dayan, N‐C. Ganderup, and K.L. Hastings, eds.) pp. 185‐209. CRC Press/Taylor & Francis, Boca Raton, Fla.
   Maxwell, C.V., Wettmann, R.P., and Walters, L.E. 1976. Plasma CPK as an indicator of stress susceptibility in swine. Anim. Sci. Res. Oklahoma Agricultural Experiment Station, 97‐101,
   Milano, S. 2012. Chapter 11. The minipig in safety pharmacology. In The Minipig in Biomedical Research. (P.A. McAnulty, A.D. Dayan, N‐C. Ganderup, and K.L. Hastings eds.) pp. 159‐181. CRC Press/Taylor & Francis, Boca Raton, Fla.
   Morikawa, F., Nakayama, Y., Fukuda, F., Hamano, M., Yokohama, Y., Nagura, T., Ishihara, M., and Toda, K. 1974. Techniques for Evaluation of Phototoxicity and Photoallergy in Laboratory Animals and Man. In Sunlight and Man (T.B. Fitzpatrick ed.) pp. 529‐557. University of Tokyo Press, Tokyo.
   Mortensen, J.T., Brinck, P., and Lichtenberg, J. 1998. The minipig in dermal toxicology: A literature review. Scand. J. Lab. Anim. Sci. 25:77‐83.
   Newsome, P.N., Plevris, J.N., Nelson, L.J., and Hayes, P.C. 2000. Animal models of fulminat hepatic failure: A critical evaluation. Liver Transpl. 6:21‐31.
   Nunoya, T., Shibuya, K., Saitoh, T., Yazawa, H., Nakamura, K., Baba, Y., and Takaya, H. 2007. Use of miniature pig for biomedical research with reference to toxicologic studies. J. Toxicol. Pathol. 20:125‐132.
   Padgett, E.L. 2009. Nonclinical Juvenile Toxicology: The minipig as a model for juvenile toxicity testing. WIL Research Laboratories, Minipig Research Forum of North America Conference, PPT.
   Patterson, J.K., Lei, X.G., and Miller, D.D. (2008). The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exp. Biol. Med. 233:651‐664.
   Pfister, T., Weber, K., Erny, S., and Allen, T.R. 1998. Ultrasound technology in the cardiovascular examination of minipigs. Scand. J. Lab. Anim. Sci. 25:121‐125.
   Pond, W.G. and Houpt, K.A. 1978. The Biology of the Pig. Comstock Publishing Associates, Ithaca, New York.
   Pond, W.G. and Mersmann, H.J. 2001. The Biology of the Pig. Cornell University Press, Ithaca, New York.
   Ramaiah, S.K. 2007. A toxicologist guide to diagnostic interpretation of hepatic biochemical parameters. Food Chem. Toxicol. 45:1551‐1557.
   Rothkotter, H.J., Sowa, E., and Pabst, R. 2002. The pig as a model of developmental immunology. Hum. Exp. Toxicol. 21:533‐536.
   Sambuco, C.P. 1985. Miniature swine as an animal model in photodermatology: Factors influencing sunburn cell formation. Photodermatol. 2:144‐150.
   Sambuco, C.P. and Forbes, P.D. 1984. Quantitative assessment of phototoxicity in the skin of hairless mice. Food Chem. Toxicol. 22:233‐236.
   Schwalb, D., Eshghi, M., Cord, J., Evans, R., Braga, E., Franco, I., Durso, J., and Addonizio, J.C. 1989. The minipig as a practical endourologic model. J. Endourol. 3:85‐90.
   Short, B. 2008a. Oligonucleotides Including siRNAs, in Nonclinical Ocular Safety Evaluations. Platform Presentation at ARVO 2008, PPT.
   Short, B. 2008b. Safety evaluation of ocular drug delivery formulations: Techniques and practical considerations. Toxicol. Pathol. 36:49‐62.
   Smith, A.C and Swindle, M.M. 2006. Preparation of swine for the laboratory. ILAR J. 47:358‐363.
   Soucek, P., Zuber, R., Anzenbacherov, E., Anzenbacher, P., and Guengerich, F.P. 2001. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol. 1:11.
   Sullivan, T.P., Eaglstein, W.H., Davis, S.C., and Mertz, P. 2001. The pig as a model for human wound healing. Wound Repair Regen. 9:66‐76.
   Swindle, M.M. (ed.). 2007. Chapter 7. Urinary System and Adrenal Glands. In Swine in the Laboratory: Surgery, Anesthesia, Imaging and Experimental Techniques. pp. 157‐174. CRC Press, Boca Raton, Fla.
   Swindle, M.M., Makin, A., Herron, A.J., Clubb, F.J., and Frazier, K.S. 2012. Swine as models in biomedical research and toxicology testing. Vet. Pathol. 49:344‐356.
   Svendsen, O. 2007. Chapter 15. Toxicology. In Swine in the Laboratory: Surgery, Anesthesia, Imaging and Experimental Techniques. (M.M. Swindle, ed.) pp. 373‐381. CRC Press, Boca Raton, Fla.
   Tikhonov, V.N. and Bobovich, V.E. 2012. Genetics and major applications of supersmall mini pigs in medicine and biotechnology. Russian J. Genet. Appl. Res. 2:97‐104.
   Turk, J.R. 2012. Chapter 14, Heart and cardiotoxicity. In The Minipig in Biomedical Research. (P.A. McAnulty, A.D. Dayan, N‐C. Ganderup, and K.L. Hastings, eds.) pp. 237‐241. CRC Press/Taylor & Francis,
   Twedt, D.C. 2008. Hepatology. Interpretation of Elevated Liver Enzymes. 2008 North American Veterinary Conference: Small Animal and Exotics Section Section, Orlando, Fla.
   University of Minnesota. 2011. Research Animal Resources Animal Per Diem Rates for FY12, Effective July 16, 2011.
  USDA APHIS. 2003. Animals Used in Research, in Animal Care Report: Annual Report of Enforcement by Fiscal Year, 2002, U.S. Department of Agriculture, Animal and Plant Health Inspection Service, 2003, (accessed March 17, 2005).
  USDA APHIS. 2008. Animal Care Annual Report of Activities, FY 2007. APHIS 41‐35‐075.
  USFDA. 2001. Nonclinical Assessment of Potential Hepatotoxicity in Man. November. Feb 12, 2001;‐public/@fdagov‐drugs‐gen/documents/document/ucm091453.pdf.
  USFDA. 2010. Guidance for Industry M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), January 2010 Revision 1, ICH.
   van der Laan, J‐W., Brightwell, J., McAnulty, P., Ratky, J., and Stark, C. 2010. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products. J. Pharmacol. Toxicol. Methods 62:184‐195.
   Wilson, G.D.A., Harvey, D.G., and Snook, C.R. 1972. A review of factors affecting blood biochemistry in the pig. Br. Vet. J. 128:596‐610.
   Zheng, Y., Tesar, D.B., Benincosa, L., Birnböck, H., Boswell, C.A., Bumbaca, D., Cowan, K.J., Danilenko, D.M., Daugherty, A.L., Fielder, P.J., Grimm, H.P., Joshi, A., Justies, N., Kolaitis, G., Lewin‐Koh, N., Li, J., McVay, S., O'Mahony, J., Otteneder, M., Pantze, M., Putnam, W.S., Qiu, Z.J., Ruppel, J., Singer, T., Stauch, O., Theil, F.P., Visich, J., Yang, J., Ying, Y., Khawli, L.A., and Richter, W.F. 2012. Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration. MAbs 1;4(2).
PDF or HTML at Wiley Online Library